Q&A with Candriam’s Thomson: A science-led, transparent regulatory process is key for biotech sector
Cuts to US FDA funding are fuelling fears of delays to drug approvals that could kickstart a biotech stock selloff
Candriam
-
-
Candriam adds market-neutral ESG fund to its suite of funds
Invests long in companies recognised as sustainability leaders
-
Paint it blue: Closing the water gap
Candriam’s Czupryna and Dublanc say that consuming less water and better management could help conserve resources in the short-term
-
Candriam launches Article 9 thematic water fund
Investing in water solutions enablers and leaders
-
Candriam launches sustainable EM ex-China fund
Amid greater demand for products in the sector
-
Business Benchmark on Animal Welfare relaunches with tougher criteria
Companies including Amazon Whole Foods, Domino’s Pizza and Müller rated ‘F’
-
Shareholders vote against ShareAction’s resolution for improved Nestlé health targets
But ‘direction of travel is clear’ as for businesses heavily reliant on unhealthy foods
-
ESG assets set to reach over £7.7trn by 2027
Year-on-year surge in assets directed towards Article 8 and 9 in 2023
-
World Health Day: How AI plays a pivotal role in advancing healthcare
Investors expect AI to provide ‘the greatest potential for transformative impact’ in this vital sector
-
Investors file resolution to challenge Nestlé over public health impact
Filing a shareholder resolution after dialogue reaches ‘impasse’
-
Over 100 financial firms among early adopters of TNFD recommendations
‘A milestone moment for nature finance and corporate reporting’
-
PRI-backed sovereign engagement group expands
The Collaborative Sovereign Engagement on Climate Change has expanded to include 18 new investors